ERBB3 (P21860) variants and mutations
ERBB3 (also known as P21860) is a human protein-coding gene encoding a receptor tyrosine-protein kinase erbB-3 protein. It amplifies neuregulin and ERBB-family signaling primarily by heterodimerizing with catalytically active partners such as HER2 and strongly recruiting PI3K. Persistent signaling can promote tumor growth and resistance to targeted therapy. This analysis covers 3,272 ERBB3 variants and mutations. Of these, 50% have computational variant effect predictions. Disease context includes visceral neuropathy, familial, 1, autosomal recessive, lethal congenital contracture syndrome 2, and cancer. Example ERBB3 variants include R2G, R2K, and R2W.
Variant analysis overview
- Gene: ERBB3
- Protein: P21860
- UniProt accession: P21860
- Organism: Homo sapiens
- Variants analyzed: 3272
- Variant scope: all variants
- Completed: 2026-08-18
Variant and mutation evidence
- Variant composition: 3,060 unspecified-consequence records; 103 missense variants; 79 synonymous variants; 5 stop-gained variants; 17 frameshift variants; 4 splice-region variants; 2 in-frame deletions; 1 stop lost; 1 substitution
- Prediction scores: 1,640 variants have prediction scores (50% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: visceral neuropathy, familial, 1, autosomal recessive, lethal congenital contracture syndrome 2, cancer, urinary bladder cancer, urinary bladder carcinoma, Lethal congenital contracture syndrome type 2, non-small cell lung carcinoma, neoplasm, medullary thyroid gland carcinoma, colorectal adenocarcinoma, erythroleukemia, familial, susceptibility to, gastric adenocarcinoma.
Protein structure and variant hotspots
- Protein features: 1 transmembrane segments; 1 domains; 4 binding sites; 12 post-translational modification sites.
- Structural context: 598 variants have structural context.
- PTM context: 26 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable ERBB3 variants
Examples include R2G, R2K, R2W, R2M, R2S, A3G, A3T, A3E. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- R2G (p.Arg2Gly), TOPMed rs1410872951, gnomAD rs1410872951, REVEL 0.21, MetaLR 0.22, Uncertain significance, not specified
- R2K (p.Arg2Lys), gnomAD rs1448565511, REVEL 0.05, MetaLR 0.20
- R2W (p.Arg2Trp), gnomAD 12-56080304-A-T, REVEL 0.21, CADD 25.60
- R2M (p.Arg2Met), gnomAD 12-56080305-G-T, REVEL 0.14, CADD 22.90
- R2S (p.Arg2Ser), gnomAD 12-56080306-G-T, REVEL 0.09, CADD 22.60
- A3G (p.Ala3Gly), TOPMed rs1868337458, REVEL 0.05, MetaLR 0.18
- A3T (p.Ala3Thr), Ensembl rs1868337425, REVEL 0.06, MetaLR 0.23
- A3E (p.Ala3Glu), gnomAD 12-56080308-C-A, REVEL 0.21, CADD 16.80
- A3V (p.Ala3Val), gnomAD 12-56080308-C-T, REVEL 0.05, CADD 16.10
- A3A (p.Ala3Ala), gnomAD 12-56080309-G-T, CADD 9.11
- N4S (p.Asn4Ser), gnomAD 12-56080311-A-G, REVEL 0.04, CADD 0.53
- N4N (p.Asn4Asn), gnomAD 12-56080312-C-T, CADD 4.64
- N4K (p.Asn4Lys), gnomAD 12-56080312-C-A, REVEL 0.18, CADD 0.35
- D5N (p.Asp5Asn), TOPMed rs1868337487, REVEL 0.07, MetaLR 0.20
- D5Y (p.Asp5Tyr), gnomAD 12-56080313-G-T, REVEL 0.16, CADD 12.80
- D5E (p.Asp5Glu), gnomAD 12-56080315-C-A, REVEL 0.04, CADD 14.60
- D5D (p.Asp5Asp), rs1173842446, gnomAD 12-56080315-C-T, CADD 13.90
- A6T (p.Ala6Thr), ExAC rs757100419, TOPMed rs757100419, gnomAD rs757100419, REVEL 0.04, MetaLR 0.18
- A6V (p.Ala6Val), TOPMed rs1432269330, gnomAD rs1432269330, REVEL 0.05, MetaLR 0.18
- A6S (p.Ala6Ser), gnomAD 12-56080316-G-T, REVEL 0.03, CADD 22.20
- A6D (p.Ala6Asp), gnomAD 12-56080317-C-A, REVEL 0.23, CADD 22.90
- A6A (p.Ala6Ala), gnomAD 12-56080318-T-G, CADD 15.60
- L7P (p.Leu7Pro), gnomAD rs1173594365, REVEL 0.30, MetaLR 0.48
- L7M (p.Leu7Met), gnomAD 12-56080319-C-A, REVEL 0.18, MetaLR 0.49
- L7Q (p.Leu7Gln), gnomAD 12-56080320-T-A, REVEL 0.26, MetaLR 0.48
- L7L (p.Leu7Leu), gnomAD 12-56080321-G-C, CADD 14.60
- Q8E (p.Gln8Glu), Ensembl rs2136781330, MetaLR 0.19, MetaSVM -0.81
- Q8P (p.Gln8Pro), Ensembl rs1868337663, REVEL 0.15, MetaLR 0.26
- Q8* (p.Gln8Ter), gnomAD 12-56080322-C-T, CADD 38.00
- Q8R (p.Gln8Arg), gnomAD 12-56080322-CA-C, CADD 32.00
- Q8K (p.Gln8Lys), gnomAD 12-56080322-C-A, REVEL 0.14, MetaLR 0.18
- Q8L (p.Gln8Leu), gnomAD 12-56080323-A-T, REVEL 0.21, MetaLR 0.10
- V9G (p.Val9Gly), TOPMed rs1868337744, MetaLR 0.26, MetaSVM -0.51, Uncertain significance, not specified
- V9L (p.Val9Leu), TOPMed rs933549006, gnomAD rs933549006, REVEL 0.07, MetaLR 0.19
- V9M (p.Val9Met), TOPMed rs933549006, gnomAD rs933549006, REVEL 0.13, MetaLR 0.40
- V9A (p.Val9Ala), gnomAD 12-56080326-T-C, REVEL 0.04, MetaLR 0.22
- V9V (p.Val9Val), rs2136781353, gnomAD 12-56080327-G-A, CADD 17.30
- L10M (p.Leu10Met), ExAC rs767359947, TOPMed rs767359947, gnomAD rs767359947, REVEL 0.14, MetaLR 0.40
- L10L (p.Leu10Leu), gnomAD 12-56080328-C-T, CADD 16.30
- L10P (p.Leu10Pro), gnomAD 12-56080329-T-C, REVEL 0.30, MetaLR 0.43
- G11D (p.Gly11Asp), gnomAD rs1287546945, REVEL 0.19, MetaLR 0.28
- G11S (p.Gly11Ser), gnomAD rs1868337864, REVEL 0.14, MetaLR 0.19
- G11V (p.Gly11Val), gnomAD rs1287546945, REVEL 0.19, MetaLR 0.19
- G11A (p.Gly11Ala), gnomAD 12-56080329-TG-T, CADD 28.00
- G11C (p.Gly11Cys), gnomAD 12-56080331-G-T, REVEL 0.14, MetaLR 0.24
- G11G (p.Gly11Gly), rs750252178, gnomAD 12-56080333-C-T, CADD 14.60
- L12L (p.Leu12Leu), gnomAD 12-56080334-T-C, CADD 16.10
- L12S (p.Leu12Ser), gnomAD 12-56080335-T-C, REVEL 0.17, MetaLR 0.28
- L12F (p.Leu12Phe), gnomAD 12-56080336-G-T, REVEL 0.06, MetaLR 0.24
- L13I (p.Leu13Ile), gnomAD 12-56080337-C-A, REVEL 0.03, MetaLR 0.24
- L13F (p.Leu13Phe), gnomAD 12-56080337-C-T, REVEL 0.03, MetaLR 0.24
- L13R (p.Leu13Arg), gnomAD 12-56080338-T-G, REVEL 0.30, MetaLR 0.49
- L13P (p.Leu13Pro), gnomAD 12-56080338-T-C, REVEL 0.29, MetaLR 0.49
- F14S (p.Phe14Ser), rs2136781388, gnomAD 12-56080337-CT-C, CADD 29.90
- F14L (p.Phe14Leu), gnomAD 12-56080340-T-C, REVEL 0.07, MetaLR 0.12
- F14Y (p.Phe14Tyr), gnomAD 12-56080341-T-A, REVEL 0.05, MetaLR 0.24
- S15N (p.Ser15Asn), gnomAD rs1441975473, MetaLR 0.21, MetaSVM -0.88
- S15R (p.Ser15Arg), gnomAD 12-56080345-C-A, REVEL 0.15, MetaLR 0.21
- L16M (p.Leu16Met), gnomAD 12-56080346-C-A, REVEL 0.17, MetaLR 0.44
- L16P (p.Leu16Pro), gnomAD 12-56080347-T-C, REVEL 0.33, MetaLR 0.42
- L16L (p.Leu16Leu), gnomAD 12-56080348-G-A, CADD 16.10
- A17T (p.Ala17Thr), rs755757062, NCI-TCGA Cosmic COSV9991, cosmic curated COSV99916, ExAC rs755757062, REVEL 0.07, MetaLR 0.21, Variant assessed as somatic; moderate impact.
- A17V (p.Ala17Val), gnomAD rs1233610855, REVEL 0.06, MetaLR 0.16
- A17P (p.Ala17Pro), gnomAD 12-56080347-TG-T, CADD 32.00
- A17S (p.Ala17Ser), gnomAD 12-56080349-G-T, REVEL 0.06, MetaLR 0.18
- A17D (p.Ala17Asp), gnomAD 12-56080350-C-A, REVEL 0.21, MetaLR 0.21
- A17A (p.Ala17Ala), gnomAD 12-56080351-C-A, CADD 15.80
- R18L (p.Arg18Leu), cosmic curated COSV10585, NCI-TCGA TCGA novel, TOPMed rs1317504479, gnomAD rs1317504479, REVEL 0.27, MetaLR 0.17, Variant assessed as somatic; moderate impact.
- R18Q (p.Arg18Gln), TOPMed rs1317504479, gnomAD rs1317504479, REVEL 0.04, MetaLR 0.19
- R18R (p.Arg18Arg), rs779598315, gnomAD 12-56080352-C-A, CADD 16.30
- R18W (p.Arg18Trp), gnomAD 12-56080352-C-T, REVEL 0.15, MetaLR 0.39
- R18G (p.Arg18Gly), gnomAD 12-56080352-C-G, REVEL 0.17, MetaLR 0.23
- R18P (p.Arg18Pro), gnomAD 12-56080353-G-C, REVEL 0.26, MetaLR 0.25
- G19S (p.Gly19Ser), cosmic curated COSV10725, ExAC rs748811895, gnomAD rs748811895, REVEL 0.07, MetaLR 0.11
- G19C (p.Gly19Cys), gnomAD 12-56080355-G-T, REVEL 0.14, MetaLR 0.29
- G19V (p.Gly19Val), gnomAD 12-56080356-G-T, REVEL 0.12, MetaLR 0.16
- G19D (p.Gly19Asp), gnomAD 12-56080356-G-A, REVEL 0.14, MetaLR 0.19
- G19G (p.Gly19Gly), rs1868338364, gnomAD 12-56080357-C-A, CADD 15.30
- S20F (p.Ser20Phe), cosmic curated COSV57262, ExAC rs34379766, TOPMed rs34379766, gnomAD rs34379766, REVEL 0.24, MetaLR 0.36
- S20P (p.Ser20Pro), Ensembl rs2136781481, REVEL 0.21, MetaLR 0.22
- S20Y (p.Ser20Tyr), rs34379766, UniProt VAR 042101, ExAC rs34379766, TOPMed rs34379766, REVEL 0.21, MetaLR 0.36
- S20S (p.Ser20Ser), rs1254446175, gnomAD 12-56080360-C-T, CADD 15.70
- E21K (p.Glu21Lys), ExAC rs778250041, TOPMed rs778250041, gnomAD rs778250041, REVEL 0.22, MetaLR 0.14
- E21Q (p.Glu21Gln), ExAC rs778250041, TOPMed rs778250041, gnomAD rs778250041, MetaLR 0.21, MetaSVM -0.82
- E21R (p.Glu21Arg), rs768059072, gnomAD 12-56080358-TC-T, CADD 31.00
- E21* (p.Glu21Ter), gnomAD 12-56080361-G-T, CADD 39.00
- E21G (p.Glu21Gly), gnomAD 12-56080362-A-G, REVEL 0.08, MetaLR 0.23
- E21D (p.Glu21Asp), gnomAD 12-56080363-G-T, REVEL 0.06, MetaLR 0.21
- E21E (p.Glu21Glu), gnomAD 12-56080363-G-A, CADD 13.20
- V22E (p.Val22Glu), gnomAD rs1868338618, REVEL 0.13, MetaLR 0.20
- V22M (p.Val22Met), cosmic curated COSV10585, TOPMed rs1171426421, gnomAD rs1171426421, REVEL 0.11, MetaLR 0.17
- V22A (p.Val22Ala), gnomAD 12-56080365-T-C, REVEL 0.15, MetaLR 0.17
- V22V (p.Val22Val), gnomAD 12-56080366-G-A, CADD 19.10
- G23D (p.Gly23Asp), gnomAD rs1868338709, REVEL 0.14, MetaLR 0.24
- G23R (p.Gly23Arg), gnomAD rs1868338662, REVEL 0.14, MetaLR 0.26
- G23S (p.Gly23Ser), gnomAD rs1868338662, REVEL 0.12, MetaLR 0.20
- G23C (p.Gly23Cys), gnomAD 12-56080367-G-T, REVEL 0.14, MetaLR 0.45
- G23G (p.Gly23Gly), gnomAD 12-56080369-C-T, CADD 22.40
- N24K (p.Asn24Lys), gnomAD rs1408056133, REVEL 0.06, MetaLR 0.17
- N24D (p.Asn24Asp), gnomAD 12-56080370-A-G, REVEL 0.06, MetaLR 0.19
- S25P (p.Ser25Pro), gnomAD 12-56080373-T-C, REVEL 0.18, MetaLR 0.38
- S25Y (p.Ser25Tyr), gnomAD 12-56080374-C-A, REVEL 0.20, MetaLR 0.32
- S25S (p.Ser25Ser), rs1391410330, gnomAD 12-56080375-T-C, CADD 14.60
- Q26E (p.Gln26Glu), gnomAD rs1868338819, REVEL 0.04, MetaLR 0.26
- Q26K (p.Gln26Lys), gnomAD 12-56080376-C-A, REVEL 0.09, MetaLR 0.22
- Q26R (p.Gln26Arg), rs1403022338, gnomAD 12-56080376-CA-C, CADD 27.10
- Q26* (p.Gln26Ter), gnomAD 12-56080376-C-T, CADD 39.00
- Q26P (p.Gln26Pro), gnomAD 12-56080377-A-C, REVEL 0.17, MetaLR 0.28
- Q26L (p.Gln26Leu), gnomAD 12-56080377-A-T, REVEL 0.14, MetaLR 0.32
- Q26H (p.Gln26His), gnomAD 12-56080378-G-T, REVEL 0.19, MetaLR 0.45
- Q26Q (p.Gln26Gln), rs190034531, gnomAD 12-56080378-G-A, CADD 14.30
- A27T (p.Ala27Thr), ExAC rs771442726, gnomAD rs771442726, REVEL 0.05, MetaLR 0.30
- A27S (p.Ala27Ser), gnomAD 12-56080379-G-T, REVEL 0.04, MetaLR 0.25
- A27V (p.Ala27Val), gnomAD 12-56080380-C-T, REVEL 0.07, MetaLR 0.33
- A27E (p.Ala27Glu), gnomAD 12-56080380-C-A, REVEL 0.12, MetaLR 0.23
- V28L (p.Val28Leu), gnomAD 12-56080382-G-C, REVEL 0.13, MetaLR 0.42
- V28V (p.Val28Val), rs747687493, gnomAD 12-56083752-G-A, CADD 14.30
- C29R (p.Cys29Arg), ExAC rs757712749, gnomAD rs757712749, REVEL 0.87, MetaLR 0.69
- P30L (p.Pro30Leu), rs56017157, ClinGen CA6621830, ClinVar RCV000994933, ClinVar RCV003962975, REVEL 0.10, MetaLR 0.34, Conflicting interpretations, Lethal congenital contracture syndrome 2; Visceral neuropathy, familial, 1, auto
- P30T (p.Pro30Thr), Ensembl rs1868388166, REVEL 0.06, MetaLR 0.22
- P30P (p.Pro30Pro), rs746211618, gnomAD 12-56083758-T-C, CADD 8.21
- T32I (p.Thr32Ile), Ensembl rs2136785629, REVEL 0.41, MetaLR 0.65
- L33P (p.Leu33Pro), Ensembl rs2136785639, MetaLR 0.47, MetaSVM -0.19
- L33L (p.Leu33Leu), rs770120793, gnomAD 12-56083765-C-T, CADD 10.40
- L33V (p.Leu33Val), gnomAD 12-56083765-C-G, REVEL 0.03, MetaLR 0.32
- G35V (p.Gly35Val), TOPMed rs1868388612, MetaLR 0.61, MetaSVM 0.26
- G35D (p.Gly35Asp), gnomAD 12-56083772-G-A, REVEL 0.25, MetaLR 0.53
- L36P (p.Leu36Pro), Ensembl rs2136785661, MetaLR 0.64, MetaSVM 0.36
- L36L (p.Leu36Leu), rs1475856748, gnomAD 12-56083774-C-T, CADD 12.40
- V38M (p.Val38Met), Ensembl rs2136785664, MetaLR 0.41, MetaSVM -0.32
- T39A (p.Thr39Ala), Ensembl rs750029748, REVEL 0.18, MetaLR 0.36
- T39I (p.Thr39Ile), Ensembl rs2136785684
- T39N (p.Thr39Asn), Ensembl rs2136785684, MetaLR 0.53, MetaSVM 0.03
- T39T (p.Thr39Thr), rs749408634, gnomAD 12-56083785-C-G, CADD 1.23
- G40S (p.Gly40Ser), cosmic curated COSV57254, ExAC rs774536437, TOPMed rs774536437, gnomAD rs774536437, REVEL 0.28, MetaLR 0.32
- G40G (p.Gly40Gly), rs762010415, gnomAD 12-56083788-C-T, CADD 2.71
- D41G (p.Asp41Gly), Ensembl rs2136785705, MetaLR 0.43, MetaSVM -0.16
- D41N (p.Asp41Asn), rs374953448, ClinGen CA6621839, cosmic curated COSV57249, ClinVar RCV003147108, REVEL 0.08, MetaLR 0.31, Uncertain significance, not provided
- D41E (p.Asp41Glu), gnomAD 12-56083791-T-G, REVEL 0.19, MetaLR 0.31
- A42G (p.Ala42Gly), Ensembl rs2136785713
- A42T (p.Ala42Thr), rs760515344, ClinGen CA6621840, ClinVar RCV004212074, ExAC rs760515344, REVEL 0.10, MetaLR 0.24, Uncertain significance, not specified
- A42V (p.Ala42Val), Ensembl rs2136785713, MetaLR 0.15, MetaSVM -0.85
- E43K (p.Glu43Lys), cosmic curated COSV10957, ExAC rs766147426, gnomAD rs766147426, REVEL 0.10, MetaLR 0.30
- E43E (p.Glu43Glu), gnomAD 12-56083797-G-A, CADD 10.20
- N44S (p.Asn44Ser), gnomAD 12-56083799-A-G, REVEL 0.06, MetaLR 0.16
- Q45* (p.Gln45Ter), Ensembl rs2136785734
- Q45K (p.Gln45Lys), NCI-TCGA TCGA novel, REVEL 0.14, MetaLR 0.43, Variant assessed as somatic; moderate impact.
- Y46D (p.Tyr46Asp), NCI-TCGA Cosmic COSV9991, cosmic curated COSV99916, MetaLR 0.45, MetaSVM -0.09, Variant assessed as somatic; moderate impact.
- Y46H (p.Tyr46His), gnomAD 12-56083804-T-C, REVEL 0.28, MetaLR 0.49
- Y46Y (p.Tyr46Tyr), rs753681468, gnomAD 12-56083806-C-T, CADD 10.90
- Q47H (p.Gln47His), gnomAD rs1376142104, MetaLR 0.36, MetaSVM -0.51
- Q47Q (p.Gln47Gln), rs1376142104, gnomAD 12-56083809-G-A, CADD 10.60
- T48I (p.Thr48Ile), ExAC rs759044259, gnomAD rs759044259, MetaLR 0.42, MetaSVM -0.22
- T48T (p.Thr48Thr), rs764891356, gnomAD 12-56083812-A-T, CADD 2.89
- L49P (p.Leu49Pro), gnomAD 12-56083814-T-C, REVEL 0.54, MetaLR 0.65
- L49L (p.Leu49Leu), rs2136785770, gnomAD 12-56083815-G-A, CADD 9.58
- Y50* (p.Tyr50Ter), gnomAD rs1243750809, CADD 35.00
- Y50Q (p.Tyr50Gln), rs764925612, gnomAD 12-56083813-CTG-C, CADD 25.50
- Y50H (p.Tyr50His), gnomAD 12-56083816-T-C, REVEL 0.13, MetaLR 0.24
- Y50C (p.Tyr50Cys), gnomAD 12-56083817-A-G, REVEL 0.20, MetaLR 0.44
- L52P (p.Leu52Pro), TOPMed rs1485348787, gnomAD rs1485348787, REVEL 0.33, MetaLR 0.48
- Y53C (p.Tyr53Cys), rs752180033, ExAC rs752180033, TOPMed rs752180033, gnomAD rs752180033, REVEL 0.65, MetaLR 0.61, Variant assessed as somatic; moderate impact.
- Y53Y (p.Tyr53Tyr), rs992281120, gnomAD 12-56083827-C-T, CADD 7.09
- E54K (p.Glu54Lys), ExAC rs757941835, TOPMed rs757941835, gnomAD rs757941835, REVEL 0.05, MetaLR 0.29
- E54V (p.Glu54Val), NCI-TCGA TCGA novel, MetaLR 0.36, MetaSVM -0.66, Variant assessed as somatic; moderate impact.
- R55G (p.Arg55Gly), ExAC rs781661153, TOPMed rs781661153, gnomAD rs781661153, REVEL 0.19, MetaLR 0.14
- R55W (p.Arg55Trp), ExAC rs781661153, TOPMed rs781661153, gnomAD rs781661153, REVEL 0.24, MetaLR 0.35
- R55R (p.Arg55Arg), rs1868390505, gnomAD 12-56083833-G-A, CADD 11.40
- C56R (p.Cys56Arg), gnomAD 12-56083834-T-C, REVEL 0.95, MetaLR 0.99
- C56C (p.Cys56Cys), rs1202851148, gnomAD 12-56083836-T-C, CADD 10.40
- V58M (p.Val58Met), ExAC rs750947241, TOPMed rs750947241, gnomAD rs750947241, REVEL 0.62, MetaLR 0.76
- V58V (p.Val58Val), rs756656037, gnomAD 12-56083842-G-A, CADD 12.30
- V59L (p.Val59Leu), ExAC rs780212356, gnomAD rs780212356
- V59M (p.Val59Met), ExAC rs780212356, gnomAD rs780212356, MetaLR 0.81, MetaSVM 0.79
- M60I (p.Met60Ile), rs2540742315, ClinGen CA385277311, ClinVar RCV003332988, Pathogenic, Malignant tumor of urinary bladder
- M60K (p.Met60Lys), NCI-TCGA Cosmic COSV5724, cosmic curated COSV57247, NCI-TCGA Cosmic COSV5725, Ensembl rs2136785847, Variant assessed as somatic; moderate impact.
- M60L (p.Met60Leu), cosmic curated COSV57250, Ensembl rs2136785841
- M60R (p.Met60Arg), NCI-TCGA Cosmic COSV5724, NCI-TCGA Cosmic COSV5725, cosmic curated COSV57256, Ensembl rs2136785847, MetaLR 0.23, MetaSVM -0.60, Variant assessed as somatic; moderate impact.
- G61E (p.Gly61Glu), Ensembl rs2136785862, MetaLR 0.79, MetaSVM 0.63
- G61R (p.Gly61Arg), ExAC rs749691155, TOPMed rs749691155, gnomAD rs749691155, REVEL 0.93, MetaLR 0.89
Public ERBB3 analysis runs
- ERBB3 analysis run — ERBB3 (3,272 variants) — completed 2026-08-18